TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank7
3Y CAGR-56.8%
5Y CAGR-51.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-56.8%/yr
vs -17.2%/yr prior
5Y CAGR
-51.6%/yr
Recent deceleration
Acceleration
-39.6pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.42M | -17.0% |
| 2024 | $6.52M | -33.6% |
| 2023 | $9.82M | -85.4% |
| 2022 | $67.38M | -16.6% |
| 2021 | $80.75M | -60.5% |
| 2020 | $204.44M | +5.1% |
| 2019 | $194.52M | +35.5% |
| 2018 | $143.58M | +56.5% |
| 2017 | $91.77M | -13.0% |
| 2016 | $105.42M | - |